Saxenda® - NOVO NORDISK

Saxenda® diabetes medication from Novo Nordisk

Saxenda is a prescription medication used for weight management in adults with obesity or overweight conditions. It is an injectable medicine that contains the active ingredient liraglutide, which mimics the effects of the naturally occurring hormone GLP-1.

Saxenda is typically used as part of a comprehensive weight loss program that includes a reduced-calorie diet and increased physical activity. It is intended for individuals with a body mass index (BMI) of 27 or greater who have at least one weight-related condition or a BMI of 30 or greater.

calculate your bmi

How fast does Saxenda® work?

The speed at which Saxenda works can vary among individuals. Saxenda is typically administered gradually, with the dosage gradually increasing over several weeks to minimize side effects. While some people may start experiencing weight loss within a few weeks, others may take longer to see noticeable results.

It’s crucial to follow the prescribed dosage and incorporate Saxenda into a comprehensive weight loss plan that includes a reduced-calorie diet and increased physical activity. Individual responses to Saxenda can differ, and it’s essential to consult with a healthcare professional to monitor progress and adjust the treatment plan as needed.

Is it necessary to change lifestyle?

Weight loss medications such as Saxenda® are intended as a supplement to weight loss. At SLIM for LIFE, we see medicine as a starting point and support for a healthier lifestyle.

To achieve a stable and optimal weight loss course, it requires more than weight loss medication alone. A lifestyle change with a low-calorie diet, good eating habits and exercise is therefore an optimal prerequisite for achieving and maintaining healthy and effective weight loss.

Who can get Saxenda®?

To be approved for Saxenda®, you must have a BMI of at least 30 or a BMI of 27 with at least one weight-related illness, e.g.:

High blood pressure or cholesterol – cardiovascular diseases – sleep apnea – prediabetes, PCOS – weight-related cancer (breast cancer, oesophagus, colon and rectal cancer, uterus, etc.) – weight-related joint pain conditions – large waist size, i.e. men over 102 cm and women over 88 cm.

If you have diabetes, are pregnant, breastfeeding, or intend to become pregnant soon, you must not take weight loss medication with Semaglutide.

If there are other relevant health conditions, it may have an impact on whether you should be treated with Saxenda®.

At SLIM for LIFE, we are ready to help answer your questions. You are always welcome to contact us if you have any questions about the treatment or our services.

How does Saxenda® work?

The medication functions by managing blood sugar levels and reducing appetite. Saxenda® is administered through a weekly injection and requires a prescription. When coupled with a healthy diet and exercise, the medication can facilitate sustainable weight loss.

Additionally, Saxenda® diminishes cravings for sweet and fatty foods, leading to a lower calorie intake and subsequent weight loss. It serves as a supplement in the weight loss journey, complementing a lifestyle shift characterized by healthy eating habits and regular exercise. The medicine is injected once a week using a thin disposable needle, targeting the thigh, abdomen, or upper arm.

What is the difference between Saxenda® and Wegovy®?

Wegovy (semaglutide 2.4 mg) and Saxenda (liraglutide) are both medications used for weight management, but they have some differences:

  1. Active Ingredient:

    • Wegovy: Semaglutide 2.4 mg
    • Saxenda: Liraglutide

  2. Dosage:

    • Wegovy is available in a specific dosage of 2.4 mg.
    • Saxenda is available in various dosages, and the recommended dose is gradually increased over several weeks to minimize side effects.

  3. Indications:

    • Wegovy is primarily indicated for the treatment of obesity and is specifically designed for individuals with a BMI of 30 or higher or a BMI of 27 or higher with at least one weight-related comorbidity.
    • Saxenda is also indicated for weight management in individuals with obesity or overweight conditions, with a BMI of 27 or higher with at least one weight-related comorbidity or a BMI of 30 or higher.

  4. Manufacturer:

    • Wegovy and Saxenda are produced by Novo Nordisk.

  5. Dosage Forms:

    • Wegovy is available as a pre-filled pen for subcutaneous injection.
    • Saxenda is also administered through a pre-filled pen as a subcutaneous injection.

  6. Dosage Regimen:

    • Wegovy is administered once weekly.
    • Saxenda is initially started at a lower dose and gradually increased over several weeks, reaching a maintenance dose.

  7. Approval Date:

    • Wegovy received FDA approval in June 2021 for chronic weight management.
    • Saxenda has been approved for weight management for a longer period, receiving FDA approval in 2014.

While both medications are GLP-1 receptor agonists and share similarities, the specific formulation, dosing, and indications can vary. Individuals considering these medications should consult with their healthcare providers to determine the most suitable option based on their health profile and weight management goals.

Is Saxenda® safe for non-diabetics?

Yes, Saxenda® is approved for use in non-diabetic individuals. Saxenda® (liraglutide) is a prescription medication used for weight management in adults with obesity or overweight conditions. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the effects of the naturally occurring hormone GLP-1. While it was initially developed as a treatment for type 2 diabetes, it has also been found to be effective for weight loss.

Saxenda® is indicated for individuals with a body mass index (BMI) of 27 or greater who have at least one weight-related condition, or a BMI of 30 or greater. It is important for individuals to consult with their healthcare providers to determine if Saxenda® is suitable for their specific health needs and to discuss potential risks and benefits.

calculate your bmi

Get started

Information

Contact

Sign Up Newsletter

  • Join Today & Get Promotional (affiliate) Offers



    anpc
    soal
    en_USEnglish
    sv_SESvenska en_USEnglish